文献速递腹部CTMR

钆-乙氧基苄基-二乙烯三胺五乙酸增强MRI与增强CT评估肝脏肿瘤的前瞻性比较研究

Comparison of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MRI and contrast-enhanced CT evaluation of liver tumors: a prospective study.
PubMed 文献 · Abdom Radiol (NY) · 2025-08-18

这项前瞻性研究在105例因肝脏肿瘤行肝切除术的患者中比较了增强CT与Gd-EOB-MRI对肝脏病灶的诊断准确性。Gd-EOB-MRI对恶性病灶的检出敏感度显著高于增强CT(读者A:90.3% vs 68.3%;读者B:88.1% vs 70.2%),两种方法的假阳性率均较低,但模棱两可病灶常见。

要点

  • Gd-EOB-MRI对恶性病灶检出敏感度显著高于增强CT(读者A 90.3% vs 68.3%,读者B 88.1% vs 70.2%)。
  • 增强CT与Gd-EOB-MRI的假阳性率均较低(读者A 2.3% vs 3.7%,读者B 0.5% vs 4.2%)。
  • 模棱两可病灶常见(142个),联合替代检查和2名以上放射科医师评估可提高诊断准确性。

核心结论

  • Gd-EOB-MRI在检测肝脏病灶方面优于增强CT,两种方法的假阳性率均较低,模棱两可病灶常见但可通过替代检查和多名放射科医师评估提高准确性。

研究设计与样本

  • 前瞻性研究,纳入105例因肝脏肿瘤行肝切除术的患者(结直肠癌肝转移72例、肝细胞癌29例、其他4例),由2名放射科医师(读者A和B)分别评估增强CT和Gd-EOB-MRI,以术后病理及随访(未切除病灶≥1年无变化确认为良性)为参考标准。

诊断标准与关键数值

  • 病灶按5级评分:1=良性、2=可能良性、3=模棱两可、4=可能恶性、5=恶性;评分1/2定义为良性,4/5定义为恶性;未切除病灶术后≥1年无变化确认为良性。

临床应用与阅片要点

  • Gd-EOB-MRI对恶性病灶检出敏感度显著高于增强CT(读者A 90.3% vs 68.3%,P<0.001;读者B 88.1% vs 70.2%,P<0.001)。假阳性率:读者A增强CT 2.3% vs Gd-EOB-MRI 3.7%(P=0.580),读者B增强CT 0.5% vs Gd-EOB-MRI 4.2%(P=0.033)。142个病灶在至少一种影像检查中被任一读者判为模棱两可,其中68个(49%)经任何替代评估识别为恶性,61个最终确认为恶性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: This prospective study aimed to compare the diagnostic accuracy of hepatic lesions between contrast-enhanced computed tomography (CE-CT) and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging (Gd-EOB-MRI). We also examined the final diagnosis of equivocal lesions.

METHODS: In each patient undergoing hepatectomy for liver tumors, 2 radiologists (readers A and B) assessed CE-CT and Gd-EOB-MRI. Hepatic lesions were scored as 1, 2, 3, 4, or 5, which corresponded to categorization as benign, probably benign, equivocal, probably malignant, or malignant, respectively. Those scored as 1/2 and 4/5 were defined as benign and malignant, respectively. The lesions left unresected were confirmed as benign when they remained unchanged for ≥ 1 year after hepatectomy. The false-positive rate was defined as the number of lesions finally confirmed as benign among those assessed as malignant preoperatively.

RESULTS: Among 105 enrolled patients (colorectal liver metastases, 72; hepatocellular carcinoma, 29; other, 4), 886 lesions were recognized on either CT or MRI preoperatively; another 26 lesions were identified only on intraoperative ultrasonography or pathologic examination. The sensitivity of malignant lesion detection was significantly higher for Gd-EOB-MRI than CE-CT for both reader A (90.3% vs. 68.3%; P < 0.001) and reader B (88.1% vs. 70.2%; P < 0.001). The false-positive rate with CE-CT and Gd-EOB-MRI was 2.3% and 3.7%, respectively, for reader A (P = 0.580), and 0.5% and 4.2%, respectively, for reader B (P = 0.033). There were 142 lesions judged as equivocal in at least one of the imaging studies by either reader. Sixty-eight lesions (49%) were recognized as malignant by any of the alternative assessments; among these, 61were confirmed as malignant.

CONCLUSION: Gd-EOB-MRI was superior to CE-CT for detecting liver lesions. The false-positive rate was low for both modalities. Equivocal lesions were encountered frequently, but routine use of alternate modalities and evaluation by 2 or more radiologists could enhance the accuracy of diagnosis.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Kishi Y, Edo H, Mikoshi A, et al. Comparison of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MRI and contrast-enhanced CT evaluation of liver tumors: a prospective study. Abdom Radiol (NY). 2025. PMID: 40824535. doi:10.1007/s00261-025-05152-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。